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1. Introduction  
The success of gene delivery systems in in vivo or in vitro applications depends on efficient 
transfection. Cationic liposomes remain a promising alternative for nonviral DNA carriers, 
mainly because they protect DNA from interstitial fluids and easily interact with cells 
(Gregoriadis, 1993; Lasic, 1997). However, in order to be effective in the immunological 
response, cationic liposomes must be functional and reach their specific target. Stability, 
reduced toxicity, efficiency in delivering genes to cells, and specific targeting to the nucleus are 
essential requirements for prophylactic and/or therapeutic performance. In order to achieve 
these standards, important physico-chemical parameters in liposomes must be controlled, 
such as the functionality of the lipids, the concentration of the cationic lipid, DNA loading 
(reflected by the R+/- molar charge ratio), the zeta potential, size, and polydispersity. 
Several laboratory experiments have already explored DNA vaccines using cationic lipids. 
A classical investigation of lipid functionality and composition, as well as the efficiency of 
cationic liposomes as DNA carriers, was performed by Perrie and colleagues (Perrie & 
Gregoriadis, 2000; Perrie et al., 2001). The plasmid pRc/CMV HBS encoding the S (small) 
region of hepatitis B surface antigen was encapsulated in dehydrated-hydrated liposomes 
composed of egg phosphatidylcholine (EPC, bilayer-forming lipid), 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP, cationic lipid), 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE, helper lipid) in a 50:25:25 percent molar ratio. The authors 
demonstrated that the encapsulation process protects the DNA vaccine against incubation 
with sodium dodecyl sulfate (SDS) due to DNA incorporation inside the liposome lamella 
(Perrie & Gregoriadis, 2000), and a better immunological response was obtained with 
cationic liposomes compared to naked DNA.  
Concerning size and polydispersity, different authors have reported that nanoparticle size is 
an important parameter for transfection success (Ma et al., 2007; Ogris et al., 1998; Rejman et 
al., 2004; Ross & Hui, 1999; Wiewrodt et al., 2002). Indeed, most of the variability in 
transfection procedures is a consequence of non-viral gene delivery systems with high 
polydispersity index values. The polydispersity index is related to the width of the particle 
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size distribution. High polydispersity indicates that greater population fractions are out of 
the optimum size range for cell transfection (Hsieh et al., 2009).  
In this sense, a rational design associated with a technological process able to construct 
functional liposomes efficiently is needed. Otherwise, the technological processes must be 
scalable in order to guarantee the reproducibility of the formulation when more liposomes 
have to be produced for pre-clinical and clinical assays before industrial production. In 
addition, deep understanding of the phenomena involved, as well as the correlation 
among operational variables and the physico-chemical parameters, allows more precise 
control of the quality of the final product and a rational optimization of the process. 
Therefore, process and product must be strongly linked to assure the desired biological 
performance. 
The literature reports valuable results regarding the biological performance of cationic 
liposomes in vaccination and gene therapy. However, to the best of our knowledge, no study 
has yet focused on the approach connecting design, product, and production process. We 
obtained promising immunological responses and a prophylactic effect against tuberculosis 
(TB) using cationic dehydrated-hydrated liposomes (DRV) complexed to DNA containing the 
hsp65 gene on the external surface (Rosada et al., 2008). Hsp65 is a heat shock protein from M. 
leprae. The hsp65 gene has been extensively studied and its biological effects evaluated for 
protection against and the treatment of tuberculosis (de Paula et al., 2007; Silva et al., 2005). 
Formulations based on the hsp65 gene have been used in different immunization strategies 
and the evaluation of protection against M. tuberculosis challenge (Souza et al., 2008).  
We developed a novel and non-toxic formulation of cationic liposomes in which the hsp65 
DNA vaccine was entrapped or complexed on the external surface of the cationic DRV. The 
formulation was used to immunize mice by intramuscular or intranasal routes. A single 
intranasal dose of the formulation elicited humoral and cellular immune responses that 
were as strong as those induced by four intramuscular doses of naked DNA in the mouse 
model of TB. The formulation also allowed a 16-fold reduction in the amount of DNA 
administered. Moreover, this formulation was demonstrated to be safe, biocompatible, 
stable, and easy to manufacture at low cost. We think that this strategy can be applied to 
human vaccination against TB in a single dose or in prime-boost protocols with a 
tremendous impact on controlling this neglected disease (Rosada et al., 2008).   
The net positive surface charge imparted by DOTAP drives electrostatic binding to the cell 
membrane. The fusogenic properties of phosphatidylethanolamine promote the exchange of 
lipids with the endosomal membrane and delivery of DNA into the cytoplasm (Xu and 
Szoka, 1996). Finally, the presence of EPC provides stability to the liposomes, reduces the 
cytotoxicity of the cationic lipids, and delimits the diameter of liposome construction, which 
influences macrophage phagocytosis. For the same lipid composition, the complexation of 
DNA on the surface of liposomes generated more cell accessibility (non-electrostatically 
bound DNA) to DNA in relation to encapsulated DNA, and controlled antibody production 
related to DOTAP/DOPE lipoplexes (de la Torre et al., 2009). The liposomes were prepared 
using Bangham’s method (Bangham et al., 1965) and characterized according to size, 
polydispersity, and zeta potential. DNA loading and availability on the external surface of 
liposomes were also determined (Rosada et al., 2008).  
For the next pre-clinical and clinical assays, a scalable process had to be established in order to 
evaluate the capability of the system in scale transposition, reproducing the physico-chemical 
and biological properties of the previously prepared liposomes on a laboratory scale.  
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In this chapter, we review the top-down and bottom-up approaches for liposome 
production and DNA complexation aiming at gene vaccines. The technological processes are 
classified into strategies and the feasibility to scale transposition envisaged. The physico-
chemical aspects of the processes and properties of the produced liposomes are correlated, 
connecting product and process. In addition, we report our experience with a scalable 
production of  previously designed cationic  DNA-EPC/DOPE/DOTAP liposomes in a top-
down process involving ultra-turrax and microchannel microfluidizer devices for the 
homogenation and reduction of liposome size.  
2. Liposomes: Structure, formation, and characterization   
In general, amphiphile molecules, when dispersed in a liquid medium, undergo internal self-
organization, generating colloidal aggregates. Liposomes are formed through the aggregation 
of phospholipid molecules in an aqueous medium. Initially, a plain bilayer structure is formed 
when the relative volumes between the non-polar and polar parts of the phospholipid 
molecules are favorable (packing factor is close to 1) for vesiculation in closed structures. The 
timing of spontaneous self-aggregation is long, and in technological processes this time is 
reduced by promoting vesiculation via the addition of energy to the system and remotion of 
the organic solvent or detergent in which the lipids were initially dispersed (Gregoriadis, 1990; 
Lasic, 1993). Primary aggregation generates unilamellar liposomes, which undergo secondary 
aggregation, forming multilamellar liposomes (Figure 1).  
 
 
Fig. 1. Unilamellar and multilamellar liposomes.  
The main physico-chemical characterization of cationic liposomes for gene vaccines includes 
average hydrodynamic diameter and size distribution, zeta potential, and morphology. 
These characterizations have been well described in the modern literature, including 
techniques, equipment, and the software used for analyzing data.  
Regarding the average hydrodynamic diameter and size distribution, photon correlation 
spectroscopy (PCS) and dynamic laser light scattering using a Ne-He laser are generally 
used for measurements at various incidence angles. Particle diameter is calculated from the 
translational diffusion coefficient using the Stokes-Einstein equation:  
 d(H) = (kT)/(3ǑηD) (1) 
Where d(H) is the hydrodynamic diameter, D is the translational diffusion coefficient, k is 
Boltzmann's constant, T is the absolute temperature, and η is the viscosity. The mean 
diameter and size distribution are estimated by an adequate algorithm analysis. The results 
of the population distributions are expressed as the intensity of scattered light and 
automatically converted to number-weighted mean diameter and size distribution by 
adequate software. For more accurate size characterization, intensity and number-weighted 
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mean diameters are considered. Although the whole range of diameters is shown in the 
intensity-weighted distribution, the proportionality to the sixth power of particle diameter 
underestimates small particles, which are only very weakly weighted (Egelhaaf et al., 1996). 
The corresponding number-weighted distribution converted using the Mie theory is in 
equivalent proportion to the first power of the diameter and determines the actual number 
of particles yielding the observed intensity in each size class (Hulst, 1969).  
Several structural parameters involved in the process of liposome preparation can be 
studied and controlled using X-ray techniques. The simple piling of several polar lipid 
bilayers produces an X-ray diffraction pattern from which one can determine the 
periodicity, the type of lattice, and an estimate of water molecules in the interface. The 
colloidal size of self aggregates, such as the dispersion of liposomes, can be characterized by 
small angle X-ray scattering techniques directly in the liquid buffer media, complementing 
some indirect microscopy methods (Kratky 1988). Structural phase transition, swelling, 
crystallization, permeation, nucleation, and other properties will be reflected in a change in 
the scattering pattern. More than a few dimensions in polar lipid/water systems, such as, 
lattice periodicity and arrangement, aggregate size, and defects, are on the order of 
magnitude of the X-ray wavelength, a few Angstroms. The bigger the particle (up to a few 
hundred Angstroms), the smaller the scattering angle. The terms small angle X-ray 
scattering (SAXS) and wide angle X-ray scattering (WAXS) are applied. X-ray diffraction is a 
particular case of scattering for ordered systems. 
2.1 Small angle X-ray scattering (SAXS) 
Here, we present an outline of the main features of the general X-ray techniques applied 
specifically to the case of liposome characterization. For better comprehension of the theory 
of X-ray scattering, the reader may like to consult the works of Glatter (Glatter & Kratky 
1982, Glatter 1991) and Kratky (Kratky & Laggner 2001). For the notation, as a convention in 
the literature, and in order to avoid dependence on wavelength values, the scattering angle 




pi θλ= =q  
(2) 
Where q is the wave vector, 2θ the scattering angle, and λ the incident wavelength. By using 
the wave vector instead of angles, one can directly compare experiments performed with 
different X-ray wavelengths. SAXS is the elastic scattering that occurs when X-rays strike a 
sample of given material. The electrons of each atom in the sample will re-emit the same 
energy isotropically. The total scattering amplitude, or amplitude “form factor” F(q), is a 
sum of all scattered waves in all directions as defined in Equation 3,  
 ( ) ( ) i q rF q r e drρ − ⋅=       (3) 
Where ( ) i q rr eρ − ⋅
  is the amplitude of the wave scattered by an atom located at position r. The 
result is a maximum intensity in the direction of the incident beam decreasing smoothly as a 
function of the scattering angle. The intensity of the scattering will depend directly on the 
electronic density ( )rρ  of the sample, i.e., the number of electrons per unit of volume. More 
specifically, for our case, the higher the difference between the electronic densities of the 
scattering centers of the sample (e.g., liposomes) and the media (e.g., buffer solution), the 
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higher the total scattering intensity. Lipid/water systems generally contain light atoms (low 
atomic number) and, consequently, very low electronic density contrast. A way to increase 
the scattering intensity is to use high flux X-ray sources, such as synchrotrons. The SAXS 
experiment will give information on the particle/system structure. Usually, the main goal of 
the SAXS analysis is the determination of the electron density ( )rρ  . This is the so called 
inverse scattering problem since the information is given in reciprocal space. There are 
several procedures that can be applied to determine ( )rρ  . One possible approach is the 
calculation of a theoretical intensity obtained for an assumed model object and the 
comparison to the experimental data. The more information one has about the sample, the 
more consistent the model will be and, consequently, the simpler the SAXS analysis. 
Nevertheless, some parameters can be determined directly from the scattering curve, for 
instance, the radius of gyration of a particle, Rg, which is the root mean square of the 
distances of all electrons from the center of gravity of the particle. The Rg is determined 
using the Guinier method, which approximates the scattering function to a simple 
distribution in the limit of very small angles (q~0.01Å-1). A graph plotting ln I(q) versus q2 in 
the limit for very low angles might be characterized by a straight line with an angular 
coefficient proportional to Rg2. 








The two requirements for using Guinier approximation are: the sample should be a 
monodisperse colloidal system, which implies no interaction between the scattering centers, 
and the experimental data must have a minimum q such that d<pi/q, where d is the 
maximum particle dimension that can be studied (Glatter 1982). For systems of large 
unilamellar vesicles in which the dimensions of the particles are not inside the limit of SAXS 
experiments, other methods, such as visible light scattering, can be used (Glatter 2002). In 
some cases, determining the cross section distance would be interesting, such as in large 
unilamellar vesicle systems, where the thickness of the lamellae is inside the limits of the 
Guinier approximation. In this case, the graph of I(q)q2 versus q, called the “thickness 
Guinier plot”, is used to determine the radius of gyration of the thickness RT com
/ 12RT T= , were T is the bilayer thickness). Another approach is to obtain the electron 
density across the thickness of the vesicle, ǒt(x). The latter approach can be applied both for 
unilamellar of multilamellar vesicles as will be discussed next.  
2.2 X ray diffraction (XRD) 
Diffraction can be viewed as a particular case of scattering: Due to the periodicity, d, of the 
system, the sum or integration of all scattered intensities turns into an interference pattern. 
In analogy, the function S(q) which is the result of the integration, is called the “structure 
factor”. The scattering curve, or diffraction pattern, presents peaks for certain scattering 
angles, θ, which can satisfy Bragg’s condition (Azaroff 1968): 
 2 sinn dλ θ=  (5) 
Where λ is the wavelength of the incident X-ray beam and n is the order of diffraction. We 
can observe a diffraction pattern, for example, in multilamellar lipid vesicles, which have a 
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lipid bilayer periodicity on the order of 50 Å. The determination of the period of the bilayer 
is useful for characterizing the structural phase of the system and its transitions. If several 
orders of diffraction are observed, the structure factor function can be reconstructed and the 
electronic density profile of the lipid bilayer determined (Pachence & Blasie 1991). The 
incorporation of compounds inside the lipid bilayer can alter the density profile and be 
controlled (Sato et al. 2009). Also the matrix of acyl chains is a periodic arrangement with 
distances between chains on the order of 5 Å. The determination of this parameter is helpful 
for controlling the stability of the liposome. Any change in these distances will be followed 
by a dislocation of the diffraction peak. 
2.3 Simultaneous determination of form factor and structure factor  
Some systems present both form factor and structure factor. The scattering intensity from 
such a system can be written by the following expression: 
 ( ) ( ) ( )I q c P q S q=  (6) 
Where c is related to the concentration of particles in the system, P(q)=|F(q)|2 is the intensity 
form factor of the particles and carries information about particle shape and contrast and S(q) 
is the system structure factor, which carries information about possible interparticle 
interactions or arrangements. The brackets “ ” indicate that in the general case these two 
contributions have to be averaged together in the calculation. For highly anisotropic systems, 
like vesicles for example, where the transversal dimensions are much larger than the 
perpendicular dimension, the form factor can be considered as only corresponding to the 
perpendicular direction (1D function) and equation 6 can be rewritten as,  
 
2( ) ( ) ( )
c
I q P q S q
q
=  (7) 
One usual approach is to use the decoupling approximation and treat the form factor and 
structure factor separately. For a lamellar system, the structure factor is well described by 
the MCT theory (Zhang et al. 1994) 
 ( ) ( ) 2 2 2 21 ( /2 ) ( /2 )
1
1 2 1 cos  ( )
N
d q d q
n
n
S q nqd e q
N





= + −    (8) 
The average number of coherent scattering bilayers in the stack is denoted as N,  γ is Eulers’ 
constant and d the separation between layers. The Caillé parameter η involves both the 
bending modulus K of lipid bilayers and the bulk modulus B for compression (Caille 1972, 







piη =  (9) 
The description of the form factor can be done in several levels of detail. One of the simplest 
approximations is to consider a two step model given by (Nallet et al. 1993), 
 ( ) ( ) ( ) ( ){ }224 sin sin sinH H T H T T TP q q q qq ρ δ δ ρ δ ρ δ= ∆  +  − ∆ + ∆   (10) 
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Where ∆ρH and ∆ρT are respectively the head group and tail group electron density contrasts 
and δH and δT are the sizes of the head group and tail group. Following the step model 
strategy, Glatter and co-workers developed the deconvolution square root method (Glatter & 
Kratky 1982, Fritz & Glatter 2006) where the electron density is described by several step 
functions and it is applied a constrained least squares fitting routine to obtain the step heights. 
Another strategy was proposed by Pabst et.al (Pabst et al. 2000), which models the bilayer 
using a two Gaussian system: a central Gaussian placed at the origin, which can model the 
central part of the tail groups, and is known to have negative contrast with respect to a 
water buffer (when using X-Rays), and a second Gaussian placed at a certain distance Z in 
such a way that it can model the position of the head group region. This approach and the 
two step model cannot describe high quality data, principally for high q values (Oliveira et 
al. Unpublished work). In a recent development, Oliveira and co-workers combined the 
advantages of the Gaussian description with the stability introduced by the Glatter method, 
enabling a more flexible and stable model procedure.  
In this approach the profile is described by a symmetric sum of several equally spaced 
Gaussian functions. The amplitude of each Gaussian is smoothened by extra constraints. The 
constraints are used to ensure the numerical stability of the nonlinear least-square fit. By 
proper choice of the amplitude of each Gaussian it is possible to build a smooth profile that 
can describe more accurately the electron density of the bilayer. Usually, 4 Gaussians function 
are sufficient to describe a bilayer profile satisfactorily. The electron density is defined as 
 [ ] ( )4 1
1
( ) ( , , ) ( , , ) / 1n s n n s n n i
n
z a G z z G z zρ σ σ δ
=













 2 21( , , ) exp ( ) / 2
2s n n
G z z z zσ σ
σ pi
 = − −   (12) 
and the Kroninger delta function δi1 is used to avoid double counting for the central 
Gaussian. n is the order of Gaussian used. The profile is defined by the values of the 
amplitude factors an. Given a half bilayer thickness Z the centers of the Gaussians and the 
standard deviations (σ values) are defined as follows: 
 ( )
max
1 2 ,            




σ σ= − =  (13) 
This choice of the centers and standard deviations gives a reasonable overlap between the 
Gaussian functions enabling the construction of smooth profiles. A typical profile built 
using equation 11 is shown in the figure 2 (left). One of the advantages of using a Gaussian 
set of functions for the representation of the profile is that, for the one-dimensional case of 
centro-symmetric bilayers, the integral in equation 3 has one analytical solution, given by: 
 ( ) ( )
2 2
, 2 exp cos  
2 n
q




= −   
 (14) 
The final scattering amplitude is just the addition of all the F(q,n) terms: 




F q a F q n
=
=   (15) 
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Regardless the methodology to calculate the form factor, this procedure gives the scattering 
contribution from the built shape of the electron density profile. For the multilamelar 
vesicles this profile will be a repeating unit for each vesicle layer. By using the structure 
factor given from the modified Caillé theory (equation 8), the final scattering intensity is 
then given by: 
 ( ) ( ) ( ) ( )( )2 2MLV MCT diffI q F q S q N F q= +  (16) 
Where the second term gives rise to a diffusive scattering which might appear from the 
presence of single bilayers in the sample. Smearing effects, which are a consequence of the 
collimation of the camera pinholes, wavelength bandwidth, detector resolution, etc, can be 
taken into account by the use of the resolution function R(q,q), as described in the work of 
Pedersen (Pedersen et al. 1990). The final expression used to describe the data from 
multilamellar vesicles is given by: 
 




Sc1 is an overall scale factor and BG is a constant background. Both are optimized during 
data fitting. Using the above mentioned procedure it is possible to perform a full curve 
fitting, retrieving simultaneously information about the form factor and structure factor. A 




Fig. 2. Left: Construction of the electron density profile using four Gaussians (G1, G2, G3 
and G4) with four different amplitudes (-1, -0.3, 1, 0.3). They are shown in four different 
lines. The final resultant electron density profile from the Gaussian model is shown in solid 
thick line. Right: Fitting of experimental data using the 4-Gaussians approach. Open circles: 
experimental data for Egg phosphatidylcholine (EPC) liposome system. Solid curve: 
Theoretical intensity I(q). Dotted line: structure factors S(q). Dashed line: intensity form 
factor P(q). The obtained number of layers was N=50, Interplanar distance d=73.5±0.2Å, 
Caillé parameter of η=0.13±0.01 and bilayer half size of Z=30.00±0.06Å. The obtained 
electron density profile is shown in the inset. 
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3. Top-down and bottom-up approaches in processes 
In general, the processes for producing nanomaterials can be characterized as two main 
approaches, top-down or bottom-up. The top-down approach starts with large particles that 
are comminuted to a nanometric size through the application of high-energy forces. This is 
the classical approach for the majority of nanoparticle production processes. Top-down 
approaches require highly precise control of the variables of the process in order to obtain 
the narrow particle size (Mijatovic et al., 2005). Lithography is the classical example. Other 
high-energy processes include grinding, high impact homogenization, ultrasound waves, 
and extrusion through nanoporous membranes (Sanguansri & Augustin, 2006).  
Bottom-up approaches are based on the self-organization of molecules under 
thermodynamic control, generating nanostructures from atoms and molecules as a result of 
the effects of the chemical, physical, and process interventions on the balance of the 
intermolecular and intramolecular forces of the system components (Sanguansri & 
Augustin, 2006). Bottom-up approaches focus on the construction of functional materials, 
mimetizing the hierarchic organization of the molecules in live organisms, though the 
science still does not dominate the complex auto-aggregate structures in nature.   
Regarding liposome production, top-down approaches comprise the high-energy 
comminution of a polydispersed population of multilamellar liposomes formed under non-
controlled aggregation. The bottom-up approach manipulates the phospholipid molecules 
in controlled local aggregation in space and time, generating a monodispersed population of 
nano-sized unilamellar liposomes. Figure 3 illustrates top-down and bottom-up approaches 
for liposome production.  
 
 
Fig. 3. Scheme of top-down and bottom-up approaches for liposome production. 
4. Technological processes  
Most of the conventional methods for liposome production require an additional unit 
operation for size reduction and polydispersity, as they are top-down approaches. In this 
approach, liposomes are produced from the hydration of a thin film of lipids using Bangham’s 
method (Bangham et al., 1965), multitubular system (Torre et al., 2007; Tournier et al., 1999), 
detergent depletion or emulsion methods, ether/ethanol injection, and reverse phase 
evaporation (Lasic, 1993; New, 1990). All of these processes are discontinuous and only the 
ether/ethanol injection and multitubular system are scalable. Shearing or impact strategies are 
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the general key for homogenation and reducing liposome size. Mechanical stirring, extrusion 
through orifices (French press), extrusion through membranes, high-pressure impactor, and 
microchannel microfluidizer are equipment used in high-energy processes.   
Bottom-up  processes are low energy processes inspired by biological systems and used for 
the development of functional nanomaterials, such as supramolecular structures, self-
aggregated monolayers, Langmuir-Blodgett films, aggregated peptide nanotubes, and 
deposited polyelectrolites or proteins in multilayers (Mijatovic et al., 2005; Shimomura & 
Sawadaishi, 2001).  
Microfluidic systems have been the main representatives of bottom-up processing for 
liposome production in continuous and scaled up processes. Different microfluidic systems 
can be applied to the production of liposomes and giant liposomes (Ota et al., 2009; Shum et 
al., 2008; Wagner et al., 2002). DNA complexation on the external surface of liposomes also 
constitute a promising technology for the production of gene vaccines.   
4.1 Microfluidic systems for the production of cationic liposomes 
Among different microfluidic geometries, hydrodynamic focusing (HF) is a promising 
technology and liposomes can be produced in sizes ranging from 50 to 500 nm (Jahn et al., 
2004, 2007; Wagner et al., 2002). The HF consists of a device with four-microchannel 
intersection geometry (Figure 4A). The organic solvent, miscible in water (isopropanol, 
ethanol), containing dispersed lipids are injected in the middle stream and 
hydrodynamically compressed by two aqueous (or buffered) streams. The precise upstream 
flow rates are achieved using syringe pumps that control the position of the focused stream 
in the downstream channel and, consequently, the process quality parameters (Baldas & 
Caen, 2010). The use of stereo microscopy is recommended to monitor the process as 
presented in the schematic representation of the experimental apparatus in Figure 4B. The 
laminar flow rate allows the formation of a well defined region between the two miscible 
fluids. The interfacial forces between two miscible solvents (for example, water and 
isopropanol or water and ethanol) control the convective-diffusive process and liposome 
self-assembly (Jahn et al., 2010). From the phenomenological point of view, the continuous 
flow mode allows the continuous diffusion of water and alcohol, reducing lipid solubility, 
which causes thermodynamic instability and generates liposomes (Jahn et al., 2008). The 
continuous flow mode also increases productivity. 
The HF geometry for liposome production is based on the conventional method of ethanol 
injection (bulk) adapted for microfluidic systems. Conventional ethanol injection consists of 
the controlled addition of an ethanol/lipid stream in a tank reactor containing buffered 
water under controlled agitation. The advantage is the use of ethanol; compared to other 
organic solvents (e.g., chloroform and methanol), it is less harmful and, depending on the 
lipid concentration, there may be no need for post-treatment size reduction (Kremer & 
Esker, 1977). Some of the disadvantages are low lipid concentration in ethanol (higher 
concentrations require post-treatment for size reduction) and a difficulty achieving 
reproducibility (Wagner et al., 2002).  
The representative parameters for liposome size and polydispersity control in HF are 
channel geometry (deep and width), volumetric flow buffer/alcohol rate-ratio (FRR), and 
total volumetric flow rate (buffer+alcohol flow rates). Solvent diffusivity in water is another 
important parameter (Jahn et al., 2004, 2007, 2010). Basically, the narrower the microchannel 
width, the smaller the liposome size. For total volumetric flow rate, which promotes flow 
velocity at the channel, higher FRRs (which corresponds to an increased proportion of buffer 
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to lipid/solvent flow) correspond to smaller liposome diameter (Janh et al., 2010). However, 
caution is required in this flow rate analysis as the final alcohol content in the liposome 
colloidal dispersion can change with FRR and as a consequence of particle size. Alcohol can 
be used to disrupt liposomes and, at low concentrations, liposome size can be increased due 
to alcohol incorporation into the bilayer. Precise analysis can be performed if the alcohol is 
removed after liposome processing. By decreasing the total volumetric flow rate,  
the residence time can be increased and a lower average vesicle diameter and narrower size 
distribution obtained. This behavior indicates that if increasing the total volumetric flow 
rate, the microchannel length must be longer to complete the alcohol diffusion, otherwise 
large particles will be obtained due to bulk mixing downstream of the channel (Janh et  





Fig. 4. (A) Schematic representation of hydrodynamic focusing (HF) in a microfluidic device 
with four-channel intersection geometry. The organic solvent (miscible in water) containing 
the dispersed lipids is injected in the middle stream and hydrodynamically compressed by 
two aqueous (or buffered) streams. The flow is in the x direction and alcohol diffusion is in 
the y direction. (B) Schematic representation of the experimental apparatus for liposome 
production using HF: (1) microfluidic device; (2) water syringe pumps; (3) syringe pump for 
lipids/ethanol stream; (4) collector flask; (5) stereo microscopy; (6) computer data 
acquisition (adapted from Zhang et al., 2008). 
The lipid concentration in alcohol is also another important parameter for controlling size. 
The development of vaccines for in vivo applications requires the highest drug-loading 
capacity. In terms of gene vaccines, the DNA-loading capacity correlates with the cationic 
lipid content, defined by the molar charge rate (R+/-) between the cationic charges (from the 
cationic lipid) and negative charges (from the DNA). The R+/- and total lipid content are 
project parameters for scaling up (or scaling out) processes. As an example, the R+/- of the 
tuberculosis gene vaccine is 10 and the total lipid concentration 64 mM (Rosada et al., 2008). 
These parameters require cationic liposome production in a high lipid concentration under 
unusual microfluidic conditions. Aiming to explore the effect of lipid concentration on 
microfluidic HF processes, we investigated the influence of high lipid content (100 mM) and 
lipid composition in ethanol (EPC or EPC/DOTAP/DOPE) as a function of average size. We 
understand that the studied molar concentration is greater than the lipid solubility in 
ethanol (approximately 4 mM for EPC) (New, 1990) and, in this case, the lipid dispersion 
offers an additional barrier to ethanol diffusion into water. Based on this assumption, we 
simulated the required microchannel length for complete ethanol diffusion from a central 
stream (after HF) as a function of the lipid concentration in the ethanol stream considering 
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the mass continuity equation (according to Figure 4A), without a chemical reaction 
(Equation 18). This simulation was performed based on a microfluidic glass device 
produced by the wet photolithographic process. The microchannels were etched with HF 
solution; upstream channels measured 140 ± 1 µm in width and downstream channels  
200 ± 1 µm after the T junction. The microchannel was 50 ± 2 µm deep and the diffusion 
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Where DEW is the ethanol diffusion coefficient in water and CE is the ethanol concentration. 
The Cartesian coordinates are used because the microchannel area presents rectangular 
geometry. Considering laminar flow in x direction and mass transfer along the y direction 
(Figure 4A), Equation 18 can be adapted for short times according to the Higbie penetration 











= −  (19) 
Where t is the quotient between the difference in flow rates (water and ethanol) and distance 
x. The influence of lipid concentration was considered an additional barrier for ethanol 
diffusion due to the presence of lipid aggregates dispersed in the ethanol stream. In this 
case, the ethanol diffusion depends on the concentration gradient through ethanol/water 
streams, as well as its hydrophobic characteristics, with similar behavior as ethanol diffusion 
from aqueous solution to a phospholipid bilayer (Galindo-Rodriguez et al., 2004). The 
hydrophobic characteristics of the lipid can be expressed as the partition coefficient 
octanol/water (Po/w= 0,478). In this context, DEW was corrected by the partition coefficient 
according to Equation 20. 
 
, 0,478 *EW EWD D=  (20) 
Where DEW´ is the effective diffusion coefficient.  
Figure 5 presents the simulation of the distance (x) for total ethanol diffusion as a function of 
ethanol flow rate (at a fixed FRR of 6.26 and 20). Increasing the lipid concentration in the 




Fig. 5. Simulation of the distance for total ethanol diffusion into the water stream. The lipid 
(EPC) concentration was considered as an additional barrier to ethanol diffusion. (A) FRR = 
6.26. (B) FRR = 20. 
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According to the simulation, ethanol dispersion requires the lowest length for ethanol 
diffusion for a lipid concentration of 100 mM (among the simulated concentrations). 
Experimental evaluations with this lipid concentration were performed at different total 
flow velocities (total flow rate) and lipid compositions (EPC and EPC/DOTAP/DOPE – 
cationic liposomes) as presented in Table 1. The average diameter is strongly influenced by 
the total flow velocity and lipid composition. Decreasing the flow velocity decreases the 
average size, and this behavior is not dependent on the FRR. This parameter is associated 
with the residence time inside the microchannel, suggesting that higher residence time is 
required to control liposome size. Another interesting parameter is the lipid composition. 
The viscosity of the ethanol dispersion was 1.07 and 1.21 cP for EPC/DOTAP/DOPE and 
EPC, respectively. Lower viscosity probably offers lower mass transfer resistence, reflecting 
smaller diameters (and standard deviations) and polydispersity index values. This 
difference reflected in HF is confirmed by stereomicroscopic observation along the 
microchannel. A high polydispersity index (Table 1) can also indicate the possibility for 
further process optimization in terms of flow velocity, FRR, and lipid concentration. 
 
Lipid composition Total flow velocity (cm/min) FRR Z-average (nm)
Polidispersity 
index 
EPC 5.6 6 342.8 ± 134.5 0.427 ± 0.140 
4 7 271.6 ± 37.5 0.408 ± 0.145 
EPC/DOTAP/DOPE 8.1 10.6 162.1 ± 88.13 0.606 ± 0.157 
6.1 7.7 92.92 ± 10.14 0.441 ± 0.028 
FRR: volumetric flow buffer/alcohol rate-ratio. 
Total lipid concentration of 100 mM in ethanol stream. 
Table 1. Average liposome size (Z-average) obtained at different lipid compositions and 
flow rates. 
4.2 Microfluidic systems for electrostatic complexation of DNA  
The electrostatic interactions between DNA and cationic liposomes produce particles with 
different sizes and morphology (Mannisto et al., 2002; Oberle et al., 2000) that depend on 
R+/-, buffer ionic strength, order of component addition, reaction conditions, and the type of 
lipids (Mount et al., 2003; Zelphati et al., 1998). In this context, HF can also be used to control 
the diffusion process for DNA compaction, producing well organized aggregates. The flow 
velocity is the major parameter controlling the aggregation process (Dootz et al., 2006). 
Otten et al. (2005) investigated the HF microfluidic device to produce cationic liposome-
DNA complexes (Figure 6). The DNA solution is introduced in the central stream and the 
cationic liposome stream introduced at a lateral position. The average liposome size was 200 
nm (composed of 1:1 DOTAP and DOPC with a lipid concentration of 25 mg.mL-1), and the 
DNA was calf thymus (5 mg.mL-1). The flow velocity was 100 mm.s-1, varying with vLiposome 
= 13vDNA and vLipossomas = 130vDNA, where v is the flow velocity. The authors concluded that 
the complex is formed in two steps. The first step relates to the formation of a multilamellar 
complex, followed by the second step in which DNA is organized inside the lamellae. The 
central stream can be focused according the FRR, and reducing the diffusional length allows 
faster mixing (Knight et al., 1998).  
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A micromixer (Jellema et al., 2010) and multi-inlet microfluidic HF (MF) system (Koh et al., 
2010) were recently investigated as alternatives for producing the liposome-DNA 
complexes. These studies point out new and promising alternatives aiming to control the 
aggregation process between DNA and cationic liposomes. 
5. Physico-chemical aspects  
The processes that use top-down strategies for liposome production differ according to the 
remotion of solvent and/or application of shear. The remotion of solvent is carried out by 
evaporation (Bangham´s method or multitubular system), spray drying or evaporation in 
reverse phase, sublimation (dehydration–hydration), or solubilization in water by 
ether/ethanol injection in diluted or concentrated phases. The incomplete remotion of 
solvent has a direct impact on liposome size.  
We have observed that the presence of organic solvent in spray-dried lipid structures 
generates more amorphous or more crystalline domains due to the packing of lipids in the 
bilayers (Alves and Santana, 2004). The operational conditions interfere with the drying rate, 
and mass transfer limitations result in the complete evaporation of ethanol. The higher the 
evaporation rate, the higher the amount of ethanol remaining inside the particles because a 
shield of packed lipids close to the surface and more amorphous structures are formed. At a 
slower rate of evaporation, it is more controlled, generating more crystalline structures. The 
subsequent hydration of the solid particles with different levels of crystallinity influences 
the size and polydispersity of the generated liposomes.  
Similar mass transfer limitations are present when the organic solvent is removed by 
diffusion in water. A compromise between the diffusion and vesiculation rates controls 
particle size. The opposite rates of diffusion and hydration depend on the barrier created by 
the phospholipids, which is a function of its concentration and depends on the interaction 
among lipids. In previous studies, we characterized the packing of pseudo-ternary mixed 
Langmuir monolayers of EPC/DOTAP/DOPE using surface–molecular area curves. The 
interactions and miscibility behavior were inferred from the curves by calculating the excess 
free energy of the mixture (ΔGExc). The deviation from ideal showed dependence on the 
lipid polar head type and monolayer composition (Rigoletto et al., 2011).  
The rates of vesiculation and solvent diffusion are comparable in magnitude only at very 
low lipid concentrations, generating small liposomes in an excess of water. Under other 
conditions, the barrier created by the extension of the primary aggregation of lipids delays 
solvent remotion, generating large multilamellar liposomes. Otherwise, the rate of 
vesiculation is associated with the hydrophobicity of the non-polar groups. Therefore, the 
vesiculation rate in the primary aggregate controls liposome size. When cationic lipids are 
used, such as in the DOTAP/DOPE/EPC system, the electrostatic repulsion among the 
molecules benefits solvent diffusion and hydration, generating smaller liposomes.  
Because of the softness of the primary aggregate and the bilayer fluidity imparted by the 
phase transition temperature, liposomes are prone to fusion due to the non-ordered 
Brownian movement of the colloids in the medium, and multilamellar vesicles are generated 
in a broad range of sizes. The remaining solvent generates polydispersed liposomes, which 
are more favorable for fusion. However, charged lipids stabilize liposomes. Therefore, mass 
transfer is critical in discontinuous processing, controlling liposome size and polydispersity.  
Despite limitations in mass transfer and interactions, discontinuous processes are still 
preferable due to the simplicity in carrying out massive liposome production and scaling up 
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processes. In this context, the development of technologies that promote the production of 
cationic liposomes with controlled size and low polydispersity index, with low energy 
consumption and the elimination of organic solvents, is still a challenge.  
Continuous processes in microchannels with HF reduce the limitations due to mass transfer 
in the interface of the primary aggregate, and the continuous operation decreases 
interactions among particles due to Brownian movement. Therefore, particle size is 
controlled by the relative flow rates between the phases and by microchannel length.  
6. A case study of the production of cationic liposomes and gene vaccines in 
scalable top-down processing 
Although top-down strategies are important and high shear processing has various uses, no 
systematic studies have been carried out on the effects of liposome comminution on the 
physico-chemical and surface properties of liposomes. The data in the literature are sparse 
in regards to the kind of impellers, comminution equipment, or type of lipids used.  
Aiming to produce the gene vaccine composed of EPC/DOTAP/DOPE liposomes with 
DNA complexed on their external surface, we initially studied the significance of the process 
variables for the properties of liposomes composed of egg lecithin. Mechanical forces were 
used for homogenation and comminution in Caules type stirrer, Ultra-Turrax, and 
microchannel microfluidizer equipment. A main variable was selected and its effects on the 
physico-chemical properties of the liposomes characterized. Finally, a scalable 
discontinuous process was established and EPC/DOTAP/DOPE liposomes produced and 
complexed with DNA. The physico-chemical and biological properties of the gene vaccine 
were compared with our previous gene vaccine prepared using Bangham’s method.  
6.1 Effects of the process variables on liposome properties 
6.1.1 Statistical analysis 
We studied the effects of the shear rate using multi-factorial statistical experimental 
planning (Montgomery 2008) in order to delineate the relative importance and influence of 
the shear rate and feed flow rate on the mean diameter, polydispersity, zeta potential, and 
viscosity of egg lecithin liposomes. The liposomes were prepared with high lipid 
concentration (300 mM), aiming for applications in scaling up processes. Food grade egg 
lecithin (60% phosphatidylcholine content) from Degussa (GmbH Germany) and ethanol 99-
100% from Labsynth ltda. (São Paulo- Brazil) were used as the lipid and solvent, 
respectively.  
Figure 7 shows the experimental outline for liposome preparation. The 300 mM ethanol-
lipid suspension in a beacker (1) was fed at a previously defined flow rate through a 
peristaltic pump (2) into  the bottom of a 150 mL beaker with four fins containing pure Milli 
Q water (3). Continuous mechanical stirring was provided by a Caules type stirrer or Ultra-
Turrax® IKA T25 (Ika Works) (4). The final lipid concentration was 50 mM. After the 
feeding was complete, stirring was maintained for an additional 15 min. Comminution was 
also carried out in a microchannel microfluidizer (Microfluidizer® M-110P) with 100 mL of 
a liposome dispersion pre-processed through an Ultra-Turrax® at 5000 to 21000 s-1 shear 
rate and 0.09 to 0.96 mL.s-1. The microfluidizer worked in the pressure range of 200 to 1500 
bar and for various passages. All liposome dispersions were stored at 8°C for 12 hours 
before characterization.  
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Fig. 7. Scheme of the experimental set-up used for liposome preparation using (A) Ultra-
Turrax® or Caules mechanical stirrer. 1) Tank containing the lipid dispersion in ethanol; 2) 
peristaltic pump; 3) tank with four fins containing (150 mL) water; 4) Ultra-Turrax® or 
Caules mechanical stirrer. (B) Microchannel microfluidizer system processed the samples 
from the Ultra-Turrax®.  
6.1.2 Significance of shear and feed flow rates  
The effects of the shear rate and feed flow rate on the mean diameter, polydispersity, and 
zeta potential are presented in Table 2 and in terms of the significance of the independent 
variables and their interaction in the Pareto graphics in Figure 8. For the Caules type stirrer, 
the effects of shear rate and feed flow rate on the mean diameter of liposomes were not 
significant (Figure 8A1). The shear rate was significant for polydispersity (Figure 8A2), and 
both variables were significant for zeta potential (Figure 8A3). The interactions between the 
variables were not significant for the three response variables.  
 
 






1 2 Diameter (nm) Polydispersity Zeta Potential (mV)
-1 -1 386.10 0.37 -53.73
1 -1 254.73 0.31 -56.33
-1 1 550.20 0.58 -53.73
1 1 246.50 0.35 -48.57
0 0 374.83 0.47 -55.90
0 0 359.00 0.36 -54.60





1 2 Diameter (nm) Polydispersity Zeta Potential (mV)
-1 -1 626.17 0.65 -55.00
1 -1 414.87 0.51 -71.27
-1 1 616.47 0.68 -57.50
1 1 446.77 0.51 -52.60
0 0 582.77 0.65 -57.27
0 0 642.67 0.58 -55.80
0 0 567.40 0.62 -56.00
Factors
1: Shear rate (s-1) 
2: Inlet lipid solution flow rate (mL/s)   
Factors
1: Shear rate (s-1) 
2: Inlet lipid solution flow rate (mL/s)   
Experiment
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Data obtained using ultra-turrax showed a significant influence of the shear and feed flow 
rates, as well as their interactions, on the mean diameter and polydispersity (Figure 8B1,B2). 
However, these variables had no significant effect on the zeta potential (Figure 8B3). The 
mean diameter was influenced more by shear rate, whereas both shear rate and feed flow 




Fig. 8. Pareto´s graphic  for liposome production using (A) Caules and (B) Ultra-Turrax® 
stirrers. (A1,B1)  mean diameter hidrodinâmico médio cumulativo, (A2,B2) polydispersity, 
(A3,B3) zeta potential. 
The results show that the shear rate range of the Caules stirrer did not comminute the 
aggregates less than 600 nm in size, but it destroyed the progressive aggregations, 
influencing the polydispersity and zeta potential. However, the higher shear rates provided 
by the ultra-turrax better control phospholipid aggregation, generating smaller liposomes. 
Control is strongly dependent on the intensity of shear, and sizes in the range of 200 nm 
were obtained at the superior shear rate limit (21530 s-1) provided by the equipment. Feed 
flow rate influence mainly occurs at the inferior shear rate limit (2860 s-1). Though the shear 
rate range for ultra-turrax interferes with primary liposome aggregation, the zeta potential 
is not influenced. Therefore, for egg lecithin (300 mM concentration) liposomes, the shear 
rate range between 1000 and 21430 s-1 delimits the liposome size from approximately 600 to 
200 nm.  
6.1.3 Effects of the shear rate on the liposome properties 
Mean diameter - Additional data allowed the construction of the curve presented in Figure 
9A. The curve shows a clear relationship between liposome comminution and shear rate, 
with the mean diameter exponentially decaying with applied shear rate. The error bars are 
higher at lower shear rates due to the poor homogenization of liposomes provided by the 
lower pumping capabilities of the mechanical systems. 
The microchannel microfluidizer, working in the pressure range of 200 to 1500 bars, 
provided shear rates in the range of 2×105 to 6×105 s-1 .The data from the microchannel 
microfluidizer were obtained for pre-treated liposomes using Ultra-Turrax at shear and feed 
flow rates of 5600 to 24000 s-1 and 0.09 to 0.96 mL.s-1, respectively. The results show that the 
pre-formed liposomes reached the nanometric range (100 nm) in only one passage using 
Ultra-Turrax and the high shear rate range of the microchannel microfluidizer.  
This comminution behavior agrees with the results reported by Diat et al. (1993a). Through 
a balance between elastic and viscous forces in the liposomes, the mean diameter is reduced 
according to the square root of the applied shear rate (Equation 21).  
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Fig. 9. Cumulative hydrodynamic mean diameter as a function of the shear rate  provided 
by Caules stirrer, Ultra-Turrax®, or microchannel microfluidizer. (A) Z-average values 
obtained from light scattering measurements. (B) Linear relationship from Equation 21 
proposed by Diat et al. (1993a).  
 












Where R is the liposome radius at equilibrium, k and k are the average and Gaussian elastic 
constant of the membrane, respectively, µ is the viscosity of the liposome dispersion, 紘岌  is the 
shear rate, and d is the interlamellar distance. The different slopes for the straight lines in 
Figure 9B were obtained for the shear rate ranges of the devices used, agreeing with the 
mass balance between elastic and viscous forces in the liposomes described by Diat et al. 
(1993b). Higher shear rates produce higher slopes, indicating the presence of liposomes with 
higher elastic constant, lower viscosity, and shorter interlamellar distance.  
6.1.3.1 Viscosity, surface tension, and zeta potential 
The shear rate also reduced the viscosity of the liposome dispersion from 5 to 2 mPa, but no 
significant changes were observed in the surface tension as a consequence of the reduction 
in size. However, the reduction in size also resulted in rearrangement of the lipids in the 
external layer, changing the zeta potential from -50 to -40 mV.  
6.1.3.2 Lamellar packing 
Small angle X-ray scattering (SAXS) characterization showed changes in the interlamellar 
distances for the applied shear rate ranges (Figure 10). The distance decreased with higher 
shear rates. The decreasing interlamellar distance was a consequence of the loss of 
interlamellar water, calculated to be up to 12% for the highest level of shear rate, as well as 
of lipid packing in the liposome, found to be less than 2%. The water layer is calculated as 
the difference between the full period and the bilayer thickness (see Table 4). These factors 
may explain the observed changes in zeta potential and the different slopes of the straight 
lines obtained for the studied shear rate ranges. In addition to the interlamellar distance and 
packing, the elasticity of the bilayer may also be influenced by the shear rate and changes in 
the elastic constants determined. In general, elastic modulus is not the same as stiffness. 
Elastic modulus is a property of the constituent material, whereas stiffness is a property of 
the structure. In the case of liposomes, the elastic modulus is an intensive property of the 
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lipids, and stiffness is an extensive property dependent on the structure and packing of the 
aggregate. Therefore, we associated the changes in the slope of the straight lines in Figure 9B 
with changes in the elastic constants as a consequence of the changes in packing in the 
liposomes.   
 



































Fig. 10. Left: Small angle X-ray scattering (SAXS) profiles determined for the liposomes 
treated under moderate shear (extruded through polycarbonate membranes) and high shear 
produced by Ultra-Turrax® (21430 s-1) and microchannel microfluidizer devices (6 961 000 s-1). 






no shear 76.7±0.2 59,9±0.1 3.2±0.1 0.18±0.02 
Extrusion 73.4±0.1 59,3±0.1 3.4±0.1 0.26±0.01 
Turrax 72.5±0.2 59,1±0.1 4.1±0.1 0.26±0.01 
Microfluid 72.3±0.1 59,2±0.2 2.3±0.1 0.09±0.01 
N is the average number of bilayers and η is the Caillé parameter. 
Table 3. Structural parameters obtained from full curve modeling of SAXS data. 
6.1.3.3 Morphology 
Figure 11 presents transmission electronic microscope images of the liposomes under 
various shear treatments compared to control (Bangham’s method). 
 
A  B   C  
Fig. 11. Transmission electronic microscopy of liposomes obtained using (A) Bangham’s 
method followed by extrusion in membranes, (B)  ultra-turrax under a shear rate of  
21430 s-1, (C) microchannel microfluidizer under a shear rate 6 961 000 s-1. Bars :200nm 
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Under low shear, the liposome surface looks thicker (Figure 11A), whereas it looks more 
packed with ultra-turrax treatment (Figure 11B). However, in both cases the liposome 
morphology is spherical. Under the highest shear, the morphology of the liposomes was not 
spherical, and irregularities in the surface reflect stretching of the aggregated structure 
(Figure 8C). These results reflect the observed change in packing and zeta potential as a 
consequence of the shear rate.  
6.1.4 Scalable top-down process for liposome production  
The scalable process described in Figure 12 was established based on these results and 
validated for the production of EPC/DOPE/DOTAP liposomes. Previous assays (data not 
shown) validated the changes in the purity of EPC from 99-100% (analytical grade) to 96-
98% (commercial grade) and the lipid concentration from 16 mM (used in the Bangham’s 
method) to 64 mM.  
The injection of ethanol was used modified for the higher lipid concentration. Lipid 
concentration in the ethanol phase was previously optimized with an aim to minimize the 
concentration of ethanol in the liposome formulation, as well as prevent obstructions of the 




Fig. 12. Schematic diagram of the scalable process for cationic liposome production. 
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7. Conclusions  
The top-down and bottom-up approaches are valuable for liposome production. By 
understanding the physico-chemical aspects and behavior of variables involved in the 
process, we can establish a conscious scalable process for liposome production and connect 
functional liposomes, the performance of the production process, and the final properties of 
the gene vaccine as a product. The results presented in this chapter open opportunities for 
the development of new gene or non-gene vaccines in future research using scalable top-
down and bottom-up processes.  
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